Empagliflozin Delays Need for Insulin Initiation in Patients with Type 2 Diabetes and Cardiovascular Disease: Findings from EMPA-REG OUTCOME

被引：1
|
作者：
Vaduganathan, Muthiah
Sattar, Naveed
Fitchett, David H.
Ofstad, Anne Pernille
Brueckmann, Martina
George, Jyothis T.
Verma, Subodh
Mattheus, Michaela
Wanner, Christoph
Inzucchi, Silvio E.
Zinman, Bernard
Butler, Javed
机构：
来源：
DIABETES | 2020年 / 69卷
关键词：
D O I：
10.2337/db20-30-OR
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
30-OR
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trial
    Ferreira, Joao Pedro
    Verma, Subodh
    Fitchett, David
    Ofstad, Anne Pernille
    Lauer, Sabine
    Zwiener, Isabella
    George, Jyothis
    Wanner, Christoph
    Zinman, Bernard
    Inzucchi, Silvio E.
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
  • [42] THE INFLUENCE OF MICROVASCULAR DISEASE ON CARDIOVASCULAR EVENTS IN TYPE 2 DIABETES: A POST HOC ANALYSIS OF EMPA-REG OUTCOME
    Verma, Subodh
    Wanner, Christoph
    Zwiener, Isabella
    Ofstad, Anne Pernille
    George, Jyothis T.
    Fitchett, David
    Zinman, Bernard
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 2037 - 2037
  • [43] THE INFLUENCE OF MICROVASCULAR DISEASE ON CARDIOVASCULAR EVENTS IN TYPE 2 DIABETES: A POST HOC ANALYSIS OF EMPA-REG OUTCOME
    Verma, S.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0E) : E193 - E193
  • [44] Cost-effectiveness of empagliflozin in the UK in an EMPA-REG OUTCOME subgroup with type 2 diabetes and heart failure
    Reifsnider, Odette S.
    Kansal, Anuraag R.
    Franke, Jennifer
    Lee, Joseph
    George, Jyothis T.
    Brueckmann, Martina
    Kaspers, Stefan
    Brand, Sarah B.
    Ustyugova, Anastasia
    Linden, Stephan
    Stargardter, Matthew
    Hau, Nikco
    ESC HEART FAILURE, 2020, 7 (06): : 3910 - 3918
  • [45] Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trial
    João Pedro Ferreira
    Subodh Verma
    David Fitchett
    Anne Pernille Ofstad
    Sabine Lauer
    Isabella Zwiener
    Jyothis George
    Christoph Wanner
    Bernard Zinman
    Silvio E. Inzucchi
    Cardiovascular Diabetology, 19
  • [46] Time to cardiovascular benefits of empagliflozin: a post hoc observation from the EMPA-REG OUTCOME trial
    Verma, Subodh
    Leiter, Lawrence A.
    Zinman, Bernard
    Sharma, Abhinav
    Mattheus, Michaela
    Fitchett, David
    George, Jyothis
    Ofstad, Anne Pernille
    Kosiborod, Mikhail N.
    Wanner, Christoph
    Inzucchi, Silvio E.
    ESC HEART FAILURE, 2021, 8 (04): : 2603 - 2607
  • [47] THE ASSOCIATION BETWEEN POLYVASCULAR DISEASE AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES: A SUB-ANALYSIS OF EMPA-REG OUTCOME
    Verma, Subodh
    Mazer, C. David
    Inzucchi, Silvio E.
    Wanner, Christoph
    Ofstad, Anne Pernille
    Johansen, Odd Erik
    Zwiener, Isabella
    George, Jyothis T.
    Butler, Javed
    Zinman, Bernard
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1859 - 1859
  • [48] Cardiovascular Outcome Trials in Diabetes: Will the EMPA-REG OUTCOME and LEADER Trials Influence Clinical Decisions in Type 2 Diabetes?
    Bajaj, Harpreet Singh
    Zinman, Bernard
    CANADIAN JOURNAL OF DIABETES, 2016, 40 (05) : 379 - 381
  • [49] Empagliflozin and Rapid Kidney Function Decline Incidence in Type 2 Diabetes: An Exploratory Analysis From the EMPA-REG OUTCOME Trial
    Hadjadj, Samy
    Cooper, Mark E.
    Steubl, Dominik
    Petrini, Michaela
    Hantel, Stefan
    Mattheus, Michaela
    Wanner, Christoph
    Thomas, Merlin C.
    KIDNEY MEDICINE, 2024, 6 (03)
  • [50] Effect of empagliflozin on cardiovascular events including recurrent events in the EMPA-REG OUTCOME trial
    Lund, S. S.
    McGuire, D. K.
    Zinman, B.
    Inzucchi, S. E.
    Anker, S. D.
    Wanner, C.
    Kaspers, S.
    George, J. T.
    Elsasser, U.
    Woerle, H. J.
    Fitchett, D.
    DIABETOLOGIA, 2018, 61 : S324 - S325
12345